|
|
Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
Letter Association between the spread of circulating tumor cells and breast cancer subtypes Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, and Jun Jiang Breast Cancer Res. 2010; 12(3): 402. Published online 2010 June 17. doi: 10.1186/bcr2582.PMCID: PMC2917023 | Free in PMC on 2010/12/17 | Research Articles High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Th Johannsson, Niklas Loman, Rosa B Barkardottir, and Åke Borg Breast Cancer Res. 2010; 12(3): R25. Published online 2010 May 6. doi: 10.1186/bcr2568.PMCID: PMC2917012 Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study Priya P Gor, H Irene Su, Robert J Gray, Phyllis A Gimotty, Michelle Horn, Richard Aplenc, William P Vaughan, Martin S Tallman, Timothy R Rebbeck, and Angela DeMichele Breast Cancer Res. 2010; 12(3): R26. Published online 2010 May 10. doi: 10.1186/bcr2570.PMCID: PMC2917014 Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni, and Franca Podo Breast Cancer Res. 2010; 12(3): R27. Published online 2010 May 12. doi: 10.1186/bcr2575.PMCID: PMC2917016 Incorporating tumour pathology information into breast cancer risk prediction algorithms Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, and Antonis C Antoniou Breast Cancer Res. 2010; 12(3): R28. Published online 2010 May 18. doi: 10.1186/bcr2576.PMCID: PMC2917017 Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Liat Goldshaid, Efrat Rubinstein, Alexander Brandis, Dadi Segal, Noa Leshem, Ori Brenner, Vyacheslav Kalchenko, Doron Eren, Tamar Yecheskel, Yoseph Salitra, Yoram Salomon, and Avigdor Scherz Breast Cancer Res. 2010; 12(3): R29. Published online 2010 May 24. doi: 10.1186/bcr2579.PMCID: PMC2917020 Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration Silvie Foldynová-Trantírková, Petra Sekyrová, Kateřina Tmejová, Eva Brumovská, Ondřej Bernatík, Wulf Blankenfeldt, Pavel Krejčí, Alois Kozubík, Tomáš Doležal, Lukáš Trantírek, and Vítězslav Bryja Breast Cancer Res. 2010; 12(3): R30. Published online 2010 May 27. doi: 10.1186/bcr2581.PMCID: PMC2917022 Senescence evasion by MCF-7 human breast tumor-initiating cells Feridoun Karimi-Busheri, Aghdass Rasouli-Nia, John R Mackey, and Michael Weinfeld Breast Cancer Res. 2010; 12(3): R31. Published online 2010 June 2. doi: 10.1186/bcr2583.PMCID: PMC2917024 Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin Kathryn E Vanderlaag, Susan Hudak, Laura Bald, Laurence Fayadat-Dilman, Manjiri Sathe, Jeff Grein, and Mary J Janatpour Breast Cancer Res. 2010; 12(3): R32. Published online 2010 June 4. doi: 10.1186/bcr2586.PMCID: PMC2917027 Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm, and Jonas Manjer Breast Cancer Res. 2010; 12(3): R33. Published online 2010 June 11. doi: 10.1186/bcr2587.PMCID: PMC2917028 Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Lian Zuo, Wei Li, and Shaojin You Breast Cancer Res. 2010; 12(3): R34. Published online 2010 June 11. doi: 10.1186/bcr2588.PMCID: PMC2917029 Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort Huiyan Ma, Katherine D Henderson, Jane Sullivan-Halley, Lei Duan, Sarah F Marshall, Giske Ursin, Pamela L Horn-Ross, Joan Largent, Dennis M Deapen, James V Lacey, Jr, and Leslie Bernstein Breast Cancer Res. 2010; 12(3): R35. Published online 2010 June 18. doi: 10.1186/bcr2589.PMCID: PMC2917030 Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns Karolina Holm, Cecilia Hegardt, Johan Staaf, Johan Vallon-Christersson, Göran Jönsson, Håkan Olsson, Åke Borg, and Markus Ringnér Breast Cancer Res. 2010; 12(3): R36. Published online 2010 June 18. doi: 10.1186/bcr2590.PMCID: PMC2917031 The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, and Vinod Ganju Breast Cancer Res. 2010; 12(3): R37. Published online 2010 June 21. doi: 10.1186/bcr2591.PMCID: PMC2917032 Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development Arusha Oloumi, Mykola Maidan, Frances E Lock, Howard Tearle, Steven McKinney, William J Muller, Samuel AJR Aparicio, and Shoukat Dedhar Breast Cancer Res. 2010; 12(3): R38. Published online 2010 June 21. doi: 10.1186/bcr2592.PMCID: PMC2917033 Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, and Simon P Langdon Breast Cancer Res. 2010; 12(3): R39. Published online 2010 June 22. doi: 10.1186/bcr2593.PMCID: PMC2917034 Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang, Ana Maria Gonzalez-Angulo, Ana Lluch, Joe W Gray, Powell H Brown, Susan G Hilsenbeck, C Kent Osborne, Gordon B Mills, Adrian V Lee, and Rachel Schiff Breast Cancer Res. 2010; 12(3): R40. Published online 2010 June 22. doi: 10.1186/bcr2594.PMCID: PMC2917035 RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells Joshua A Bauer, Fei Ye, Clayton B Marshall, Brian D Lehmann, Christopher S Pendleton, Yu Shyr, Carlos L Arteaga, and Jennifer A Pietenpol Breast Cancer Res. 2010; 12(3): R41. Published online 2010 June 24. doi: 10.1186/bcr2595.PMCID: PMC2917036 Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, and Åke Borg Breast Cancer Res. 2010; 12(3): R42. Published online 2010 June 24. doi: 10.1186/bcr2596.PMCID: PMC2917037 The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells Hirokuni Ikeda, Naruto Taira, Fumikata Hara, Takeo Fujita, Hiromasa Yamamoto, Junichi Soh, Shinichi Toyooka, Tomohiro Nogami, Tadahiko Shien, Hiroyoshi Doihara, and Shinichiro Miyoshi Breast Cancer Res. 2010; 12(3): R43. Published online 2010 June 28. doi: 10.1186/bcr2598.PMCID: PMC2917038 Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, Jörg Rahnenführer, Jörg I Baumbach, Albert Sickmann, and Jan G Hengstler Breast Cancer Res. 2010; 12(3): R44. Published online 2010 June 28. doi: 10.1186/bcr2599.PMCID: PMC2917039 Reviews Tumour-associated carbohydrate antigens in breast cancer Aurélie Cazet, Sylvain Julien, Marie Bobowski, Joy Burchell, and Philippe Delannoy Breast Cancer Res. 2010; 12(3): 204. Published online 2010 June 8. doi: 10.1186/bcr2577.PMCID: PMC2917018 | Free in PMC on 2010/12/08 | The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis Jessica McCready, Lisa M Arendt, Jenny A Rudnick, and Charlotte Kuperwasser Breast Cancer Res. 2010; 12(3): 205. Published online 2010 June 17. doi: 10.1186/bcr2578.PMCID: PMC2917019 | Free in PMC on 2010/12/17 | Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression Ellen Foubert, Bram De Craene, and Geert Berx Breast Cancer Res. 2010; 12(3): 206. Published online 2010 June 25. doi: 10.1186/bcr2585.PMCID: PMC2917026 | Free in PMC on 2010/12/25 | Editorials At last, a predictive and prognostic marker for radiotherapy? Philip Coates, John Dewar, and Alastair M Thompson Breast Cancer Res. 2010; 12(3): 106. Published online 2010 May 11. doi: 10.1186/bcr2567.PMCID: PMC2917011 | Free in PMC on 2010/11/11 | What do we learn from HER2-positive breast cancer genomic profiles? Charles Theillet Breast Cancer Res. 2010; 12(3): 107. Published online 2010 June 1. doi: 10.1186/bcr2571.PMCID: PMC2917015 | Free in PMC on 2010/12/01 | Breast tumors: of mice and women Sean P McDermott and Max S Wicha Breast Cancer Res. 2010; 12(3): 108. Published online 2010 May 27. doi: 10.1186/bcr2569.PMCID: PMC2917013 | Free in PMC on 2010/11/27 | Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling Aritro Sen and Stephen R Hammes Breast Cancer Res. 2010; 12(3): 109. Published online 2010 June 16. doi: 10.1186/bcr2580.PMCID: PMC2917021 | Free in PMC on 2010/12/16 | Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition Catherine Van Poznak Breast Cancer Res. 2010; 12(3): 110. Published online 2010 June 18. doi: 10.1186/bcr2584.PMCID: PMC2917025 | Free in PMC on 2010/12/18 |
Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
|